Literature DB >> 32237998

An assessment of United States dermatology practices during the COVID-19 outbreak.

Suraj Muddasani1, Anne Housholder2, Alan B Fleischer2.   

Abstract

Objectives: The COVID-19 outbreak is a serious threat to public health and social distancing on the part of individuals can help contain the epidemic. It is unknown if dermatologists are assisting with the public health officials' recommendations for social distancing by closing their practice or limiting their practice to the treatment of emergency conditions. This study examines the activity level of dermatology practices during the United States COVID-19 outbreak.
Methods: We performed scripted phone calls to 60 dermatology practices in six different counties in the United Stated during the COVID-19 outbreak. We assessed if practices are open and if they are serving patients with urgent and non-urgent conditions.
Results: Of the 60 dermatologists selected for the study, 55 were successfully contacted (92% contact rate). Of these practices, 29 (53%) were open, 17 (31%) were only seeing urgent patients and 9 (16%) were closed. New York, New York had 2 (20%) open offices which was the lowest proportion of any county (p = .04). Counties with higher prevalence had fewer open offices (p < .01, R2 = .7).Conclusions: Many practices have restricted their level of operation especially in higher areas of COVID-19 prevalence, likely to help facilitate social distancing.

Entities:  

Keywords:  Public health; epidemic; pandemic; spread

Mesh:

Year:  2020        PMID: 32237998     DOI: 10.1080/09546634.2020.1750556

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  8 in total

1.  Impact of COVID-19 pandemic on dermatology practices: Results of a web-based, global survey.

Authors:  Shashank Bhargava; Charles McKeever; George Kroumpouzos
Journal:  Int J Womens Dermatol       Date:  2020-10-12

2.  Trends in cosmetic consumer preferences during COVID-19 pandemic: Comparing 2021 to 2020.

Authors:  Jordan V Wang; Girish S Munavalli; Christopher B Zachary; Roy G Geronemus
Journal:  J Cosmet Dermatol       Date:  2021-11-18       Impact factor: 2.189

3.  Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting.

Authors:  Bruce Strober; Dhaval Patil; Robert R McLean; Melissa Moore-Clingenpeel; Ning Guo; Eugenia Levi; Mark Lebwohl
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-13

4.  Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study.

Authors:  Fateme Shirzad Moghadam; Nika Kianfar; Shayan Dasdar; Rana Samii; Zeinab Farimani; Pedram Molhem Azar; Kamran Balighi; Robabeh Abedini; Tahereh Soori; Ali Salehi Farid; Hamidreza Mahmoudi; Maryam Daneshpazhooh
Journal:  Dermatol Ther       Date:  2022-07-21       Impact factor: 3.858

5.  Practice Patterns and Responsiveness to Simulated Common Ocular Complaints Among US Ophthalmology Centers During the COVID-19 Pandemic.

Authors:  Matthew R Starr; Rachel Israilevich; Michael Zhitnitsky; Qianqian E Cheng; Rebecca R Soares; Luv G Patel; Michael J Ammar; M Ali Khan; Yoshihiro Yonekawa; Allen C Ho; Michael N Cohen; Jayanth Sridhar; Ajay E Kuriyan
Journal:  JAMA Ophthalmol       Date:  2020-09-01       Impact factor: 7.389

Review 6.  Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies? A systematic review.

Authors:  Niloufar Najar Nobari; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

7.  Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.

Authors:  Farnoosh Seirafianpour; Sogand Sodagar; Arash Pour Mohammad; Parsa Panahi; Samaneh Mozafarpoor; Simin Almasi; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-08-06       Impact factor: 3.858

8.  Change in Allergy Practice during the COVID-19 Pandemic.

Authors:  Ayse Bilge Ozturk; Ayşe Baççıoğlu; Ozge Soyer; Ersoy Civelek; Bülent Enis Şekerel; Sevim Bavbek
Journal:  Int Arch Allergy Immunol       Date:  2020-10-15       Impact factor: 2.749

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.